Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding AG    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
04/03/2020 04/06/2020 04/07/2020 04/08/2020 04/09/2020 Date
322.7(c) 326.3(c) 316.1(c) 312.45(c) 308.2 Last
2 105 808 1 805 428 3 297 998 1 893 707 1 766 916 Volume
0.00% +1.12% -3.13% -1.15% -1.36% Change
More quotes
Financials (CHF)
Sales 2020 62 098 M
EBIT 2020 23 205 M
Net income 2020 14 713 M
Finance 2020 2 528 M
Yield 2020 2,99%
Sales 2021 63 835 M
EBIT 2021 23 961 M
Net income 2021 15 928 M
Finance 2021 10 505 M
Yield 2021 3,15%
P/E ratio 2020 18,0x
P/E ratio 2021 16,7x
EV / Sales2020 4,24x
EV / Sales2021 4,00x
Capitalization 266 B
More Financials
Company
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists... 
Sector
Pharmaceuticals
Calendar
04/22 | 01:00amSales and Revenue Release
More about the company
Surperformance© ratings of Roche Holding AG
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING AG
05:22aROCHE HOLDINGS AG : Receives a Buy rating from Barclays
MD
04:58aCHUGAI PHARMACEUTICAL : Starts Phase III Clinical Trial of Actemra for COVID-19 ..
AQ
04:57aCHUGAI PHARMACEUTICAL : Calls for the Importance of Cervical Cancer Screening on..
AQ
04/08GLOBAL MARKETS LIVE: Tesla, Boeing, Twitter…
04/08ROCHE : Invitation to Roche's live audio webcast on new AAN 2020 data
PU
04/08ROCHE : FDA Delays Decision on Risdiplam Drug
DJ
04/07PTC THERAPEUTICS : FDA Extends Risdiplam Review After Additional Data Submitted
DJ
04/07GENENTECH : Provides Regulatory Update on Risdiplam for the Treatment of Spinal ..
BU
04/07Roche provides regulatory update on risdiplam for the treatment of spinal mus..
GL
04/07Investors await data on coronavirus drugs as market rally builds
RE
04/07ROCHE HOLDINGS AG : Goldman Sachs keeps its Buy rating
MD
04/07ROCHE : FDA's Coronavirus Triage – How Pharma Can Work With The Agency To ..
AQ
04/07ROCHE : Invitation to Roche's Virtual Event “Digital technology and advanc..
PU
04/06ROCHE HOLDINGS AG : Buy rating from Deutsche Bank
MD
04/06ROCHE : UC Davis Health speeds up COVID-19 testing
AQ
More news
News in other languages on ROCHE HOLDING AG
05:22aROCHE HOLDINGS AG : Opinion positive de Barclays
02:51aEN DIRECT DES MARCHES : Air France KLM, Sodexo, Renault, Airbus, Genfit, Seb,..
04/08ROCHE : Chugai va démarrer un essai clinique sur le Covid-19
04/08Roche schliesst Lizenzvereinbarung mit Arrakis Therapeutics
04/08Roche conclut un accord de licence avec Arrakis Therapeutics
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | ROG | CH0012032048 | MarketScreener
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 354,77  CHF
Last Close Price 312,45  CHF
Spread / Highest target 29,6%
Spread / Average Target 13,5%
Spread / Lowest Target -25,1%
EPS Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
Paul Bulcke Non-Executive Director
André S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING AG0.67%274 005
JOHNSON & JOHNSON-5.75%377 684
MERCK & CO., INC-10.26%206 098
NOVARTIS-9.90%192 476
PFIZER, INC.-11.69%191 948
NOVO NORDISK A/S5.78%138 889